Dutch Biotech Booster Initiative Fuels Research and Innovation
Amsterdam, Tuesday, 18 February 2025.
The Dutch Biotech Booster subsidy supports partnerships between biotech firms and research bodies, focusing on small enterprises and startups. Applications open from 1 March to 30 May 2025.
Comprehensive Support for Biotech Innovation
The Biotech Booster program represents a significant investment in the Netherlands’ biotechnology sector, with a total budget of €24.4 million [1][2]. The initiative offers varying levels of support, funding up to 100% for fundamental research, 80% for industrial research, and 60% for experimental development projects [1]. Individual projects can receive substantial funding, with proof of principle projects eligible for up to €200,000 and proof of concept projects qualifying for maximum grants of €1,900,000 [2].
Strategic Focus Areas and Implementation
This program operates at the intersection of multiple biotech domains, including healthcare, agri-food, and biobased applications [6]. The initiative specifically targets collaborations between research institutions and biotech companies, with successful applicants required to commence their projects within six months of approval and complete them within two years [2]. Projects must demonstrate clear societal and economic value in biotechnology innovation [1].
Industry Impact and Research Network
The program strengthens the Netherlands’ position in biotechnology innovation, with support from key industry organizations like hollandbio, which represents over 280 member companies [6]. The initiative aligns with broader Dutch innovation goals, particularly in addressing challenges in healthcare and sustainability [6]. Institutional partners include leading research centers and universities across eleven Dutch provinces [1].
Future Outlook and Implementation Timeline
For 2025, the program has allocated €3 million for proof of principle projects and €1.9 million for proof of concept projects [1][2]. Applicants will receive evaluation decisions within three months of submission [2]. This structured approach aims to accelerate the translation of scientific insights into practical applications, strengthening the Netherlands’ position as a biotechnology hub [2].